Supporting more contraceptive options for women

PBAC recommends new PBS listings for oral contraception plus treatment of atopic dermatitis and severe asthma in children The PBAC has recommended listing estetrol with drospirenone (Nextstellis) on the PBS as an Unrestricted Benefit. In its decision, it referred to comments from the oral contraceptives stakeholder meeting convened in October 2024 stating that it was